ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,035.69
-1.57%
Dow Jones
37,815.92
-1.49%
US Dollar vs MXN
17.152
0.81%
Brent Oil
85.885
-1.60%
Bitcoin
59,834.13
-6.27%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Natera Inc (NTRA)

  7. Natera Inc (NTRA) Noticias

NTRA Natera Inc

93.10
-0.94 (-1.00%)
Fuera de horario
Última actualización: 15:11:48
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Natera Inc NTRA NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.94 -1.00% 93.10 15:11:48
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
93.06 92.10 94.96 92.85 94.04
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
22/4/202407:00BWNatera Announces Significant Milestone with 200+..
11/4/202407:00BWNatera Announces Publication of Largest Prospective dd-cfDNA..
08/4/202407:00BWNatera Announces New Data From Two Studies Extending the..
05/4/202406:00BWNatera Announces Positive Surveillance Analysis from the..
01/4/202407:00BWNatera and Alliance for Clinical Trials in Oncology Announce..
18/3/202406:00BWNatera Announces Phase III Randomized CIRCULATE Trial in..
14/3/202407:00BWNew KDIGO Guideline Supports Genetic Testing for the..
12/3/202407:00BWNatera to Present New Data at the 2024 SGO Annual Meeting on..
08/3/202419:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202420:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202420:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202420:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202420:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202420:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202420:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202420:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202407:00BWNatera Announces Commercial Coverage for Prospera™ Kidney..
05/3/202415:34EDGAR2Form 144 - Report of proposed sale of securities
01/3/202419:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202419:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202419:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202419:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202419:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202419:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202419:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202420:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202415:20EDGAR2Form 144 - Report of proposed sale of securities
29/2/202410:35EDGAR2Form 144 - Report of proposed sale of securities
29/2/202407:00BWNatera to Participate in March Investor Conferences
28/2/202415:11EDGAR2Form 8-K - Current report
28/2/202415:05BWNatera Reports Fourth Quarter and Full Year 2023 Financial..
27/2/202415:27EDGAR2Form 144 - Report of proposed sale of securities
27/2/202407:00BWNatera Announces Next Phase of CareDx Patent Infringement..
26/2/202406:00BWMedicare Extends Coverage of Natera’s Signatera™ MRD Test to..
23/2/202420:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202407:00BWNatera Announces Fourth Quarter and Fiscal 2023 Earnings..
08/2/202420:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202420:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202415:59EDGAR2Form 144 - Report of proposed sale of securities
06/2/202415:09EDGAR2Form 144 - Report of proposed sale of securities
05/2/202407:00BWNew Study Validates Signatera™ in Endometrial Cancer
02/2/202420:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202415:47EDGAR2Form 144 - Report of proposed sale of securities
30/1/202420:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202420:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202420:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202420:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202420:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202420:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202420:01EDGAR2Form 3 - Initial statement of beneficial ownership of..

Su Consulta Reciente

NASDAQ
NTRA
Natera
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados